TOCQUEVILLE ASSET MANAGEMENT L.P. - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 57 filers reported holding ORAMED PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.

Quarter-by-quarter ownership
TOCQUEVILLE ASSET MANAGEMENT L.P. ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2016$508,000
-56.5%
70,000
-50.0%
0.01%
-14.3%
Q2 2016$1,168,000
+150.6%
140,000
+100.0%
0.01%
+16.7%
Q1 2016$466,000
-22.2%
70,0000.0%0.01%
-25.0%
Q4 2015$599,000
+82.6%
70,000
+16.7%
0.01%
+100.0%
Q3 2015$328,000
+44.5%
60,000
+50.0%
0.00%
+33.3%
Q2 2015$227,000
-11.0%
40,0000.0%0.00%0.0%
Q1 2015$255,000
+40.1%
40,0000.0%0.00%
+50.0%
Q4 2014$182,000
-10.3%
40,000
+60.0%
0.00%0.0%
Q3 2014$203,000
+41.0%
25,000
+66.7%
0.00%
+100.0%
Q2 2014$144,000
-18.6%
15,0000.0%0.00%
-50.0%
Q1 2014$177,00015,0000.00%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
MORGAN JESS S & CO INC 576,317$1,504,0001.50%
Phoenix Holdings Ltd. 197,763$483,0000.02%
Frontier Wealth Management LLC 71,900$188,0000.02%
GSA CAPITAL PARTNERS LLP 19,659$51,0000.01%
Rossmore Private Capital 15,061$39,0000.01%
ETF MANAGERS GROUP, LLC 98,486$255,0000.01%
Virtu Financial LLC 10,450$27,0000.01%
BOURGEON CAPITAL MANAGEMENT LLC 5,627$15,0000.01%
Sterling Investment Advisors, Ltd. 3,150$8,0000.00%
Qube Research & Technologies Ltd 75,395$197,0000.00%
View complete list of ORAMED PHARMACEUTICALS INC shareholders